2/8/23 18:29 | 2/6/23 | VERA | Vera Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Sofinnova Venture Partners X, L.P. | CA | T | | P | 2,000 | 7.00 | 0 | 286 | 9 | 3,467 | D | | | | | | | | | | | | | | |
8/15/22 15:46 | 8/11/22 | CINC | Cincor Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Sofinnova Venture Partners X, L.P. | CA | T | | P | 15,000 | 30.00 | 0 | 500 | 9 | 6,074 | I | | | | | | | | | | | | | | |
2/14/22 18:17 | 2/10/22 | VERA | Vera Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Sofinnova Venture Partners X, L.P. | CA | T | | P | 4,000 | 15.00 | 0 | 267 | 9 | 3,181 | D | | | | | | | | | | | | | | |
1/13/22 16:38 | 1/11/22 | CINC | Cincor Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Sofinnova Venture Partners X, L.P. | CA | T | | P.d | 5,200 | 16.00 | 0 | 325 | 6 | 5,574 | I | | | | | | | | | | | | | | |
7/6/21 16:28 | 7/2/21 | AVTE | Aerovate Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Sofinnova Venture Partners X, L.P. | CA | T | | P.d | 5,000 | 14.00 | 0 | 357 | 10 | 3,759 | D | | | | | | | | | | | | | | |
5/18/21 20:23 | 5/18/21 | VERA | Vera Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Sofinnova Venture Partners X, L.P. | CA | T | | P.d | 8,000 | 11.00 | 0 | 727 | 33 | 2,915 | D | | | | | | | | | | | | | | |
2/9/21 18:04 | 2/9/21 | BOLT | Bolt Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Sofinnova Venture Partners X, L.P. | CA | T | | P.d | 9,000 | 20.00 | 0 | 450 | 20 | 2,754 | D | | | | | | | | | | | | | | |
7/28/20 18:08 | 7/28/20 | INZY | Inozyme Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Sofinnova Venture Partners X, L.P. | CA | T | | P.d | 7,000 | 16.00 | 0 | 438 | 28 | 2,028 | D | | | | | | | | | | | | | | |
7/1/20 21:36 | 6/30/20 | AKUS | Akouos, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Sofinnova Venture Partners X, L.P. | CA | T | | P.d | 1,000 | 17.00 | 0 | 59 | 4 | 1,515 | D | | | | | | | | | | | | | | |